dfpp

Of 50 healthy individuals selected as the control group , 10 underwent a single DFPP .

对照组：健康志愿者50名，其中10名予以双重滤过血浆置换，各1次。

Methods Double filtration plasmapheresis ( DFPP ) was used to treat 45 patients .

方法采用双滤过法血浆分离术（DFPP）治疗36例术后排斥反应和9例术前高度致敏患者。

Conclusion DFPP can decrease the level of blood lipids in patients with hyperlipemia ( P < 0.01 ) .

结论DFPP能显著降低血脂水平（P<0.01）。

Conclusion DFPP can effectively prevent hemolysis and pure red cell aplasia in recipients of unrelated bone marrow transplantation with major ABO-incompatibility .

结论双重滤过血浆成分分离法可有效预防ABO血型主要不合骨髓移植并发溶血反应和纯红再障。

A simple calibration model was developed for digital fringe projection profilometry ( DFPP ) based on absolute phase extraction and space mapping techniques to simplify the measuring system .

建立了数字光栅投影轮廓测量系统的简易标定模型，以实现测量系统的简便化和便携式应用。

AIM : To evaluate the therapeutic effects and the safety of treatment with double filtration plasmaphersis ( DFPP ) in patients with severe hyperlipemia .

目的：探讨双重滤过血浆置换（DFPP）对饮食配合内科药物治疗无效的难治性高脂血症患者的疗效及安全性。

Objective To evaluate the effect of double-filtration plasmapheresis ( DFPP ) in major ABO-incompatible unrelated allogenic bone marrow transplantation .

目的观察双重滤过血浆成分分离法在ABO血型主要不合非亲缘骨髓移植中的疗效。

Methods The red cell antibodies were removed by DFPP in 5 recipients to prevent hemolysis and pure red cell aplasia following major ABO-incompatible unrelated bone marrow transplantation .

方法采用双重滤过血浆成分分离法去除体内血型抗体，预防5例ABO血型主要不合非亲缘骨髓移植并发溶血反应和纯红再障。

Metheds In 72 patients with active rheumatoid arthritis ( the test group ), double filtration plasmapheresis ( DFPP ) was performed once a week for 2 ~ 3 sessions .

方法试验组：72例活动性RA患者，予以双重滤过血浆置换2~3次，两次之间间隔1周。

Objective To compare the curative effects and safety of immunoabsorption ( IA ) and double filtration plasmapheresis ( DFPP ) in treatment of Guillain-Barre syndrome ( GBS ) .

目的比较免疫吸附（IA）与双重血浆置换（DFPP）治疗急性Guillain-Barre综合征（GBS）的疗效及安全性。

According to the color of plasma filtrate from the first session of DFPP , the test-group was further divided as the test-group 1 , where the plasma filtrate was dark green , and the test-group 2 , where plasma filtrate was green or yellow-green .

试验组根据首次双重滤过血浆置换血浆滤出液的颜色分为试验1组：血浆滤出液呈墨绿色；试验2组：血浆滤出液呈绿色和黄绿色。